Dilip Shanghvi is the CEO of Sun Pharmaceutical. Shanghvi is based in India. Shanghvi was born in 1955 in Mumbai and educated at Bhawanipur Education Society College and The Bhawanipur Gujarati Education Society School.
Latest on The Wire
See all →IAA Leadership Awards 2026 Honour Dilip Shanghvi, Sidharth Malhotra and Industry Leaders
Aug 11 · via Press Trust of India'In the next few years, many products will come out of India that will globally help patients'
Aug 10 · via manifest-media.inNDTV Profit Business Leadership Awards: Sun Pharma's Dilip Sanghvi Wins 'Icon Of The Year' Award
Jul 26 · via NDTV ProfitA $12 Billion US Deal Pushes India’s Sun Pharma Into Big Leagues
May 4 · via Bloomberg.com
Recent developments
AI summary of recent coverageRecent coverage has focused on Dilip Shanghvi's leadership of Sun Pharmaceutical through a major expansion period, highlighted by the company's approximately $11.75 billion acquisition of Organon, which positioned Sun Pharma as a significant player in the global pharmaceutical market. Shanghvi has also received recognition through industry awards, including an Icon Of The Year award, while commenting publicly on the company's strategy to build an innovative pipeline and increase India's footprint in global pharma markets.
Summarized from the headlines below; see each source for the full story.
Key Facts
Source: Wikidata ↗- Born
- October 1, 1955 · Mumbai
- Citizenship
- India
- Education
- Bhawanipur Education Society College, The Bhawanipur Gujarati Education Society School, University of Calcutta
- Awards
- CNN-News18 Indian of the Year, Padma Shri in trade and industry
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Dilip Shanghvi, it will appear here — and tie into the news timeline.
12 stories tracked
In the News
- Press Trust of India·
IAA Leadership Awards 2026 Honour Dilip Shanghvi, Sidharth Malhotra and Industry Leaders
- TheWire.in·
IAA Leadership Awards 2026 Honour Dilip Shanghvi, Sidharth Malhotra and Industry Leaders
- manifest-media.in·
'In the next few years, many products will come out of India that will globally help patients'
- NDTV Profit·
NDTV Profit Business Leadership Awards: Sun Pharma's Dilip Sanghvi Wins 'Icon Of The Year' Award
- Bloomberg.com·
A $12 Billion US Deal Pushes India’s Sun Pharma Into Big Leagues
- Forbes·
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition
- The Economic Times·
Sun Pharma: How a small Kolkata trader became a global buyout artist
- Rediff·
What Dilip Shanghvi said on Sun Pharma's Organon Buy
- CNBC·
Sun Pharma shares jump 7% as India's largest drugmaker to buy U.S. firm Organon in $11.75 billion deal
- firstwordpharma.com·
Sun Pharma puts seal on $11.75B Organon buyout
- pharma.economictimes.indiatimes.com·
Focus on Building an Innovative Pipeline with Differentiated Assets: Dilip Shanghvi
- LinkedIn·
India Has A Limited Presence In Global Pharma: Dilip Shanghvi Of Sun Pharma
Dilip Shanghvi: FAQ
- What company does Dilip Shanghvi lead?
- Dilip Shanghvi is CEO of Sun Pharmaceutical.
- Where was Dilip Shanghvi educated?
- Dilip Shanghvi studied at Bhawanipur Education Society College, The Bhawanipur Gujarati Education Society School, University of Calcutta.